Moreover, since BMI and obesity in men are associated with increased estradiol concentrations and aromatase activity (Cohen, 2008; Colleluori et al., 2020), these changes are considered not clinically meaningful. The gene discussed is CYP19A1; the disease is obesity due to melanocortin 4 receptor deficiency.